Navigation Links
Integral Vision, Inc. Announces SharpEye(TM) Order From New Customer
Date:1/14/2008

WIXOM, Mich., Jan. 14 /PRNewswire-FirstCall/ -- Integral Vision, Inc. (OTC Bulletin Board: INVI), a leading global supplier of automated display inspection technology, today announced it has received an order for the Company's SharpEye(TM) system from a new customer. This customer is a large computer manufacturer. The SharpEye product provides analysis of functional and cosmetic defects in the display to assure quality in the manufacturing process, and the system will be used by the customer to inspect defects in LCD displays of various sizes.

"We are very pleased to receive this order. The SharpEye system will be used to establish acceptance criterion for various LCD defects. The resulting defect limits will be required to be adopted by all of the LCD suppliers to this company. We expect these specifications to generate system sales for Integral Vision from all of the LCD panel suppliers of this new customer," said Charles J. Drake, chairman and CEO of Integral Vision, Inc.

About Integral Vision

Integral Vision, Inc. (OTC Bulletin Board: INVI), an ISO 9001 registered firm, offers display inspection technology that provides analysis of functional and cosmetic defects in the display to assure quality in the manufacturing process as well as verification of the final product. Integral Vision has been inspecting displays since 1992 and is an industry leader committed to providing automated solutions to the quality issues Microdisplay, OLED and LCD manufacturers face in today's competitive marketplace. A transcript of an interview by our CEO, which gives an overview of the Company, can be found at http://www.iv-usa.com/financials/Integral.pdf. More information can be found at Website: http://www.iv-usa.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. Such statements are based on management's current expectations and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such factors and uncertainties include, but are not limited to: competitive conditions in the Company's markets and the effect of competitive products and pricing; technological development by the Company, its customers and its competition; the Company's available cash and access to debt and equity financing; and general economic conditions and conditions in the specific industries in which the company has significant customers. As a result, the Company's results may fluctuate. Additional information concerning risk factors that could cause actual results to differ materially from those projected in the forward-looking statements are contained in the Company's filings with the Securities and Exchange Commission. These forward-looking statements represent the Company's best estimates as of the date of this press release. The Company assumes no obligation to update such estimates except as required by the rules and regulations of the Securities and Exchange Commission.


'/>"/>
SOURCE Integral Vision, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology news :

1. Corporate Safe Specialists Announces Addition to Sales Team
2. e-Smart(R) Technologies, Inc., Announces Next Generation Superthin Polyimide Flexible Circuit Biometric Super Smart Card(TM) card, the i am(TM) Card.
3. Accu-Time Systems, Inc. Announces Launch of Next Generation Human Capital Management (HCM) solutions: Global Series(TM)
4. Oncolytics Biotech, Inc. announces publication of research
5. Experimental Biology and Medicine announces expansion into Asia, opens new office
6. Biophysical Society announces winners of 2008 Minority Travel Awards
7. Biophysical Society announces winners of 2008 Student Travel Awards
8. Biophysical Society announces 2008 International Travel Awards
9. bioMETRX, Inc. Announces Integration of AuthenTec Fingerprint Sensor in smartTOUCH(TM) Product Line
10. Titanium Group Announces Launch of New Identification Solution Targeting High Growth Retail Sector
11. Aware, Inc. Announces Richard Moberg to Return as CFO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
(Date:4/6/2017)... LONDON , April 6, 2017 ... Control, RFID, ANPR, Document Readers, by End-Use (Transportation & ... Energy Facility, Oil, Gas & Fossil Generation Facility, Nuclear ... Healthcare, Educational, Other) Are you looking for ... Authentication sector? ...
(Date:4/5/2017)... 2017 KEY FINDINGS The global ... a CAGR of 25.76% during the forecast period of ... factor for the growth of the stem cell market. ... MARKET INSIGHTS The global stem cell market is ... geography. The stem cell market of the product is ...
Breaking Biology News(10 mins):
(Date:4/20/2017)... Israel , April 20, 2017  BrainStorm ... stem cell technologies for neurodegenerative diseases, announced today that ... Alliance for Regenerative Medicine,s (ARM) 5 th Annual Cell ... at 09:40 EDT in Boston . ... Chief Medical Officer & Chief Operating Officer, will participate in ...
(Date:4/19/2017)... ... April 18, 2017 , ... The Vibrating Orifice Aerosol ... for generating monodisperse droplets of known diameters for research applications such as for ... particles by drying monodisperse droplets. , The VOAG requires forcing liquid out ...
(Date:4/19/2017)... ... April 18, 2017 , ... Alisa Wright, founder and ... Awards from the Purdue College of Pharmacy in Lafayette, Indiana. , The Distinguished ... for achievements in their careers and other scientific endeavors. , Wright began her ...
(Date:4/19/2017)... ... 19, 2017 , ... Nobilis Therapeutics Announces Completion of Landmark NBTX-001 ... Data in its Upcoming Post Traumatic Stress Disorder Trial , Nobilis Therapeutics, Inc. ... assessing efficacy of its NBTX-001, a xenon-based therapeutic in the treatment of Panic Disorder. ...
Breaking Biology Technology: